Proteomic analysis of low dose arsenic and ionizing radiation exposure on keratinocytes

Proteomics

Volumn 9, Issue 7, 2009, Pages 1925-1938

  Berglund, Susanne R ^a   Santana, Alison R ^b   Li, Dan ^c   Rice, Robert H ^c   Rocke, David M ^c   Goldberg, Zelanna ^d  

^a Siemens Healthcare Diagnostics   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OXiGENE Inc   (United States)

Author keywords

Arsenic; Human; Ionizing radiation; Keratinocyte; Low dose

Indexed keywords

ALPHA ENOLASE; ARSENIC; CALGRANULIN B; FATTY ACID BINDING PROTEIN; HEAT SHOCK PROTEIN 27; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; NUCLEOTIDE BINDING PROTEIN; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOBLOTTING; IONIZING RADIATION; KERATINOCYTE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RADIATION EXPOSURE; STATISTICAL ANALYSIS; TWO DIMENSIONAL ELECTROPHORESIS;

ANALYSIS OF VARIANCE; ARSENIC; CELL LINE, TRANSFORMED; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; KERATINOCYTES; PROTEINS; RADIATION, IONIZING; TANDEM MASS SPECTROMETRY;

EID: 65349114116     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800118     Document Type: Article

References (42)

1. Alavanja, M. C., Biologic damage resulting from exposure to tobacco smoke and from radon: Implication for preventive interventions. Oncogene 2002, 21, 7365-7375.
2. Hertz-Picciotto, I., Smith, A. H., Holtzman, D., Lipsett, M., Alexeeff, G., Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology 1992, 3, 23-31.
3. Hall, E. J., Wuu, C. S., Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56, 83-88.
4. Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R . et al., All-trans-retinoic acid in acute promyelocytic leukemia. N. Engl. J. Med. 1997, 337, 1021-1028.
5. Ahsan, H., Chen, Y., Parvez, F., Zablotska, L. et al., Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: Baseline results from the Health Effects of Arsenic Longitudinal Study. Am. J. Epidemiol. 2006, 163, 1138-1148.
6. Yu, H. S., Liao, W. T., Chai, C. Y., Arsenic carcinogenesis in the skin. J. Biomed. Sci. 2006, 13, 657-666.
7. Kitchin, K. T., Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 2001, 172, 249-261.
8. Klein, C. B., Leszczynska, J., Hickey, C., Rossman, T. G., Further evidence against a direct genotoxic mode of action for arsenic-induced cancer. Toxicol. Appl. Pharmacol. 2007, 222, 289-297.
9. Lau, A. T., He, Q. Y., Chiu, J. F., A proteome analysis of the arsenite response in cultured lung cells: Evidence for in vitro oxidative stress-induced apoptosis. Biochem. J. 2004, 382, 641-650.
10. Reichard, J. F., Schnekenburger, M., Puga, A., Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem. Biophys. Res. Commun. 2007, 352, 188-192.
11. Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., Mazur, M., Free radicals, metals and antioxidants in oxidative stressinduced cancer. Chem. Biol. Interact. 2006, 160, 1-40.
12. Hamadeh, H. K., Trouba, K. J., Amin, R. P., Afshari, C. A., Germolec, D., Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol. Sci. 2002, 69, 306-316.
13. Vogt, B. L., Rossman, T. G., Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - A possible mechanism for arsenite's comutagenicity. Mutat. Res. 2001, 478, 159-168.
14. Schwartz, J. L., Variability: The common factor linking low dose-induced genomic instability, adaptation and bystander effects. Mutat. Res. 2007, 616, 196-200.
15. Cook, J. A., Gius, D., Wink, D. A., Krishna, M. C. et al., Oxidative stress, redox, and the tumor microenvironment. Semin. Radiat. Oncol. 2004, 14, 259-266.
16. Tubiana, M., Aurengo, A., Averbeck, D., Masse, R., The debate on the use of linear no threshold for assessing the effects of low doses. J. Radiol. Prot. 2006, 26, 317-324.
17. Andrew, A. S., Bernardo, V., Warnke, L. A., Davey, J. C. et al., Exposure to arsenic at levels found in U.S. drinking water modifies expression in the mouse lung. Toxicol. Sci. 2007, 100, 75-87.
18. Schoen, A., Beck, B., Sharma, R., Dube, E., Arsenic toxicity at low doses: Epidemiological and mode of action considerations. Toxicol. Appl. Pharmacol. 2004, 198, 253-267.
19. Chen, G., Gharib, T. G., Huang, C. C., Taylor, J. M. et al., Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 2002, 1, 304-313.
20. Gygi, S. P., Rochon, Y., Franza, B. R., Aebersold, R., Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999, 19, 1720-1730.
21. Gottschalg, E., Moore, N. E., Ryan, A. K., Travis, L. C. et al., Phenotypic anchoring of arsenic and cadmium toxicity in three hepatic-related cell systems reveals compound- and cell-specific selective up-regulation of stress protein expression: Implications for fingerprint profiling of cytotoxicity. Chem. Biol. Interact. 2006, 161, 251-261.
22. Moore, L. E., Pfeiffer, R., Warner, M., Clark, M. et al., Identification of biomarkers of arsenic exposure and metabolism in urine using SELDI technology. J. Biochem. Mol. Toxicol. 2005, 19, 176.
23. Lee, C., Lee, Y. M., Rice, R. H., Human epidermal cell protein responses to arsenite treatment in culture. Chem. Biol. Interact. 2005, 155, 43-54.
24. Rosenfeld, J., Capdevielle, J., Guillemot, J. C., Ferrara, P., Ingel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 1992, 203, 173-179.
25. Rocke, D. M., Design and analysis of experiments with high throughput biological assay data. Semin. Cell Dev. Biol. 2004, 15, 703-713.
26. Wright, G. W., Simon, R. M., A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19, 2448-2455.
27. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodological) 1995, 57, 289-300.
28. Ivanov, V. N., Zhou, H., Hei, T. K., Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells. Cancer Res. 2007, 67, 5397-5407.
29. Bernstam, L., Lan, C. H., Lee, J., Nriagu, J. O., Effects of arsenic on human keratinocytes: Morphological, physiological, and precursor incorporation studies. Environ. Res. 2002, 89, 220-235.
30. Franco, N., Lamartine, J., Frouin, V., Le Minter, P. et al., Lowdose exposure to gamma rays induces specific gene regulations in normal human keratinocytes. Radiat. Res. 2005, 163, 623-635.
31. Ding, L. H., Shingyoji, M., Chen, F., Hwang, J. J. et al., Gene expression profiles of normal human fibroblasts after exposure to ionizing radiation: A comparative study of low and high doses. Radiat. Res. 2005, 164, 17-26.
32. Berglund, S. R., Rocke, D. M., Dai, J., Schwietert, C. W. et al., Transient genome-wide transcriptional response to lowdose ionizing radiation in vivo in humans. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70, 229-234.
33. Goldberg, Z., Rocke, D. M., Schwietert, C., Berglund, S. R. et al., Human in vivo dose-response to controlled, low-dose low linear energy transfer ionizing radiation exposure. Clin. Cancer Res. 2006, 12, 3723-3729.
34. Yang, F., Stenoien, D. L., Strittmatter, E. F., Wang, J. et al., Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. J. Proteome Res. 2006, 5, 1252-1260.
35. Zhang, B., Su, Y. P., Ai, G. P., Liu, X. H. et al., Differentially expressed proteins of gamma-ray irradiated mouse intestinal epithelial cells by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. World J. Gastroenterol. 2003, 9, 2726-2731.
36. Prasad, S. C., Soldatenkov, V. A., Kuettel, M. R., Thraves, P. J. et al., Protein changes associated with ionizing radiationinduced apoptosis in human prostate epithelial tumor cells. Electrophoresis 1999, 20, 1065-1074.
37. Ewald, N., Toepler, M., Akinci, A., Kloer, H. U. et al., Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review of current published data. Z. Gastroenterol. 2005, 43, 1313-1317.
38. Ishiguro, Y., Kato, K., Ito, T., Horisawa, M., Nagaya, M., Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor. Gann 1984, 75, 53-60.
39. Katayama, M., Nakano, H., Ishiuchi, A., Wu, W. et al., Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg. Today 2006, 36, 1085-1093.
40. Nagasue, N., Changes in lactic dehydrogenase isoenzymes after hepatic artery ligation in patients with hepatic carcinoma. Gastroenterol. Jpn. 1975, 10, 150-156.
41. Pandit, M. K., Joshi, B. H., Patel, P. S., Chitnis, K. E., Balar, D. B., Efficacy of serum lactate dehydrogenase and its isozymes in monitoring the therapy in patients with acute leukemia. Indian J. Pathol. Microbiol. 1990, 33, 41-47.
42. Sewell, D. A., Yuan, C. X., Robertson, E., Proteomic signatures in laryngeal squamous cell carcinoma. ORL J. Otorhinolaryngol. Relat. Spec. 2007, 69, 77-84.